BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion
German vaccine maker BioNTech SE (NASDAQ:BNTX) revealed on May 20 that it intends to boost its presence in the UK with an investment of up to £1 billion ($1.33 billion) over the next decade, focusing on expanding its research and development operations. According to BioNTech SE (NASDAQ:BNTX), its UK subsidiary has signed a grant agreement […]